Anxiety and Depression in Patients with Rheumatoid Arthritis: A Narrative Review of Prevalence, Associated Factors, and Clinical Implications

Saniya Siddiqua; Shreya Lucas; Zakia Nahid Seraj; Zoha Shahbaz Ahmad Shaikh; Shahi Khan; Saara Zameer; Namrah Zameer; Anjum Fathima; Adeeba Ahmad

doi:10.69968/ijisem.2026v5i3630-639

Authors

Saniya Siddiqua 3rd year Medical Student, Tashkent State Medical University
Shreya Lucas 3rd year Medical Student, Tashkent State Medical University
Zakia Nahid Seraj 4th year B.A.(H) Applied Psychology, Amity University (Kolkata)
Zoha Shahbaz Ahmad Shaikh 5th year Medical Student, Tashkent State Medical University
Shahi Khan 4th year Medical Student, Tashkent State Medical University
Saara Zameer 3rd year Medical Student, Tashkent State Medical University
Namrah Zameer 3rd year Medical Student, Tashkent State Medical University
Anjum Fathima 3rd year Medical Student, Tashkent State Medical University
Adeeba Ahmad 2nd year Medical Student, Tashkent State Medical University

DOI:

https://doi.org/10.69968/ijisem.2026v5i3630-639

Keywords:

Rheumatoid Arthritis, Anxiety and Depression, Psychological Burden, Disease Activity, Functional Disability, Quality of Life

Abstract

Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease that causes persistent joint pain, functional limitation, and disability, and it carries a substantial psychological burden. Anxiety and depression are increasingly recognized as common and clinically important comorbidities of RA that can adversely affect quality of life and disease management. This narrative review synthesizes the published literature on the prevalence of anxiety and depression among patients with RA and examines their relationship with selected demographic and clinical factors. Relevant literature was identified through a non-systematic search of PubMed, Scopus, and Google Scholar, supplemented by hand-searching of reference lists. Reported prevalence varied widely across studies: estimates of anxiety generally ranged from approximately 13.5% to 48% (with outlier estimates as low as 2.4% and as high as 77% reported within one systematic review), and estimates of depressive symptoms or disorders ranged from 14.3% to 87.2%, depending on the population studied, the diagnostic approach used, and the instruments and cut-off thresholds applied. Much of this variability reflects the distinction between structured clinical diagnoses of anxiety or depressive disorders and elevated symptom scores identified through screening instruments such as the Hospital Anxiety and Depression Scale (HADS) and the Patient Health Questionnaire-9 (PHQ-9), which are not equivalent to a clinical diagnosis. Across studies, greater pain, disease activity, functional disability, and poorer quality of life were consistently associated with higher anxiety and depression scores, and female sex and select socioeconomic factors were also frequently, though not universally, associated with psychological burden. Because nearly all of the available evidence is observational and cross-sectional, causal relationships cannot be inferred from these associations. Overall, the evidence supports incorporating routine, appropriately interpreted psychological screening into rheumatological care to enable earlier identification and more holistic, patient-centered management of RA.

References

[1]. Ahmed, A. B., Radwan, A. M. A., & Baddary, H. M. (2016). Prevalence of generalized anxiety disorder in patients with rheumatoid arthritis and its relationship with disease activity. The Egyptian Journal of Hospital Medicine, 65, 652–661. https://doi.org/10.12816/0033778

[2]. Alanazi, H. Q., Alharbi, S. A., Alghashmari, A. A., Anzi, R. N., Alawad, F. H., & Alhodibi, M. H. (2024). The prevalence and association of depression, anxiety and sleep disorders amongst adult rheumatoid arthritis patients in Saudi Arabia and its effect on health-related quality of life: A multi-centric cross-sectional study. Journal of Advanced Trends in Medical Research, 1(1), 347–353. https://doi.org/10.4103/ATMR.ATMR_139_24

[3]. Alaujan, S. S., Almalag, H. M., Alshehri, S. M., Alkendi, J. M., Almansour, M. A., Alanizy, L. N., & Omair, M. (2022). Anxiety, depression, disease disability, and health-related quality of life in rheumatoid arthritis patients during the coronavirus disease 2019 pandemic. Journal of Nature and Science of Medicine, 5(4), 348–356. https://doi.org/10.4103/jnsm.jnsm_24_22

[4]. Alharbi, S. (2023). Depression in Saudi patients with rheumatoid arthritis. Open Access Rheumatology: Research and Reviews, 15, 1–9. https://doi.org/10.2147/OARRR.S397489

[5]. Azzam, A. I., Lamlom, M., & Khalifa, A. M. (2022). Screening for depressive symptoms in patients with rheumatoid arthritis: Relationship with pain severity, disease activity, and sleep quality. Middle East Current Psychiatry, 29(1), 73. https://doi.org/10.1186/s43045-022-00239-4

[6]. Baghdadi, L. R., & Alhassan, M. K. (2025). Influence of sociodemographic and lifestyle factors on depression and anxiety in patients with rheumatoid arthritis in Saudi Arabia. International Journal of Environmental Research and Public Health, 22(11), 1625. https://doi.org/10.3390/ijerph22111625

[7]. Boshalla, N., Aljafi, N., Albraky, F., & Roaeid, R. (2024). Prevalence of depression in patients with rheumatoid arthritis attending Rheumatology Clinic of Benghazi Medical Center. Benghazi University Medical Journal, 1(1), 55–65. https://doi.org/10.37376/benunivmedj.v1i1.7141

[8]. Brahem, M., Sarraj, R., Jomaa, O., Abdellatif, S., Jebali, B., Hachfi, H., & Mohamed, Y. (2023). AB0251 Relationship between anxiety, depression and functional disability in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 82, 1309. https://doi.org/10.1136/annrheumdis-2023-eular.5085

[9]. Cheng, L., Gao, W., Xu, Y., Yu, Z., Wang, W., Zhou, J., & Zang, Y. (2023). Anxiety and depression in rheumatoid arthritis patients: Prevalence, risk factors and consistency between the Hospital Anxiety and Depression Scale and Zung's Self-Rating Anxiety Scale/Depression Scale. Rheumatology Advances in Practice, 7(3). https://doi.org/10.1093/rap/rkad100

[10]. Chijioke, C., Osadebamwen, O. S., Okere, L. A., Odogu, J. B., Onyema, E. P., Umeaku, O. J., & Richard, U. (2022). Relationship between subjective quality of life and major depression among outpatients with rheumatoid arthritis attending a Nigerian tertiary health institution. International Journal of Psychiatry Research, 5(2). https://doi.org/10.33425/2641-4317.1129

[11]. Cox, N., Hawarden, A., Kettle, C., Bajpai, R., Farooq, S., Twohig, H., Muller, S., & Scott, I. C. (2025). The relationship between pain and depression and anxiety in people with inflammatory arthritis: A systematic review. Seminars in Arthritis and Rheumatism, 74, 152808. https://doi.org/10.1016/j.semarthrit.2025.152808

[12]. Dadi, M. A., Adugna, B. A., Mulisa, M. D., Gichamo, F. G., Kassa, H. G., Anley, H. Y., Hagos, E. H., Yigzaw, H. D., Ibrahim, F., Tessema, G., & Jima, M. T. (2025). Prevalence and factors associated with anxiety and depression in rheumatoid arthritis patients in Addis Ababa, Ethiopia: A multi-center cross-sectional study. https://doi.org/10.21203/rs.3.rs-7505741/v1

[13]. Doshi, S., Oyoo, G. O., Ogola, E., & Okech-Helu, V. (2020). Depression and its association with disease activity and quality of life in patients with rheumatoid arthritis at the Kenyatta National Hospital. 8(1), 15–21.

[14]. Drakes, D. H., Fawcett, E. J., Yick, J. J. J., Coles, A. R. L., Seim, R. B., Miller, K., LaSaga, M. S., & Fawcett, J. M. (2025). Beyond rheumatoid arthritis: A meta-analysis of the prevalence of anxiety and depressive disorders in rheumatoid arthritis. Journal of Psychiatric Research, 184, 424–438. https://doi.org/10.1016/j.jpsychires.2025.03.020

[15]. Englbrecht, M., Alten, R., Aringer, M., Baerwald, C. G., Burkhardt, H., Eby, N., Flacke, J.-P., Fliedner, G., Henkemeier, U., Hofmann, M. W., Kleinert, S., Kneitz, C., Krüger, K., Pohl, C., Schett, G., Schmalzing, M., Tausche, A.-K., Tony, H.-P., & Wendler, J. (2019). New insights into the prevalence of depressive symptoms and depression in rheumatoid arthritis – Implications from the prospective multicenter VADERA II study. PLOS ONE, 14(5), e0217412. https://doi.org/10.1371/journal.pone.0217412

[16]. Feki, A., Sellami, I., Mnif, I., Abbes, A., Gassara, Z., Ben Jemaa, S., Ezzeddine, M., Kallel, M. H., Fourati, H., Akrout, R., & Baklouti, S. (2024). Psychiatric disorders in patients with rheumatoid arthritis. European Psychiatry, 67(S1), S217–S217. https://doi.org/10.1192/j.eurpsy.2024.466

[17]. Fragoulis, G. E., Cavanagh, J., Derakhshan, M. H., Paterson, C., Porter, D., McInnes, I. B., & Siebert, S. (2018). OP0350 Depression and anxiety in an early rheumatoid arthritis inception cohort: Associations with epidemiological, socioeconomic and disease features. Annals of the Rheumatic Diseases, 77, 221. https://doi.org/10.1136/annrheumdis-2018-eular.7083

[18]. Ghoreishi, F., Zamani, B., & Razaghof, M. (2016). Depressive disorder in rheumatoid arthritis: The more joints distressed, the more severely depressed. International Journal of Applied Behavioral Sciences. https://journals.sbmu.ac.ir/ijabs/article/view/11821

[19]. Golubovic, S., Ilic, T., Golubovic, B., Gajic, M., & Gajic, Z. (2023). The occurrence of depressive symptoms in rheumatoid arthritis: A cross-sectional study. Vojnosanitetski Pregled, 80(2), 128–135. https://doi.org/10.2298/VSP211125019G

[20]. Haider, M. B., Basida, B., & Kaur, J. (2023). Major depressive disorders in patients with inflammatory bowel disease and rheumatoid arthritis. World Journal of Clinical Cases, 11(4), 764–779. https://doi.org/10.12998/wjcc.v11.i4.764

[21]. Hassen, N., Moolooghy, K., Kopec, J., Xie, H., Khan, K. M., & Lacaille, D. (2025). Determinants of health-related quality of life in adults living with rheumatoid arthritis: A systematic review. Seminars in Arthritis and Rheumatism, 73, 152717. https://doi.org/10.1016/j.semarthrit.2025.152717

[22]. Ionescu, C.-E., Popescu, C. C., Agache, M., Dinache, G., & Codreanu, C. (2024). Depression in rheumatoid arthritis: Prevalence and effects on disease activity. Journal of Clinical Medicine, 13(7), 2058. https://doi.org/10.3390/jcm13072058

[23]. Ionescu, C.-E., Popescu, C. C., & Codreanu, C. (2025). Impact and prevalence of depression and anxiety in rheumatoid arthritis – A cross-sectional study with self-reported questionnaires. https://doi.org/10.20944/preprints202502.0402.v1

[24]. Isnardi, C. A., Capelusnik, D., Schneeberger, E. E., Bazzarelli, M., Berloco, L., Blanco, E., Benítez, C. A., Luján Benavidez, F., Scarafia, S., Lázaro, M. A., Pérez Alamino, R., Colombres, F., Kohan, M. P., Sosa, J., Gonzalez Lucero, L., Barbaglia, A. L., Maldonado Ficco, H., & Citera, G. (2021). Depression is a major determinant of functional capacity in rheumatoid arthritis. JCR: Journal of Clinical Rheumatology, 27(6S), S180–S185. https://doi.org/10.1097/RHU.0000000000001506

[25]. Jamshidi, T., Ghanei Gheshlagh, R., Ebtekar, F., Dalvand, S., Vahedian Azimi, A., & Kurdi, A. (2019). Prevalence of depression among Iranian patients with rheumatoid arthritis: A systematic review and meta-analysis. Open Access Rheumatology: Research and Reviews, 11, 53–59. https://doi.org/10.2147/OARRR.S191459

[26]. Juárez-Rojop, I. E., Nolasco-Rosales, G. A., Pérez-Mandujano, A., González-Castro, T. B., Tovilla-Zárate, C. A., López-Narváez, M. L., Hernández-Nuñez, É., Villar-Soto, M., & Fresan, A. (2020). Prevalence for and factors associated with depression and anxiety symptoms in Mexican patients with rheumatoid arthritis. JCR: Journal of Clinical Rheumatology, 26(7S), S111–S115. https://doi.org/10.1097/RHU.0000000000001063

[27]. Kareem, O., Ahmad, H. S., Ijaz, B., & Altaf, S. (2020). Frequency of depression in patients with rheumatoid arthritis. The Professional Medical Journal, 27(3), 646–650. https://doi.org/10.29309/TPMJ/2020.27.03.4242

[28]. Katchamart, W., Narongroeknawin, P., Chanapai, W., Thaweeratthakul, P., & Srisomnuek, A. (2020). Prevalence of and factors associated with depression and anxiety in patients with rheumatoid arthritis: A multicenter prospective cross-sectional study. International Journal of Rheumatic Diseases, 23(3), 302–308. https://doi.org/10.1111/1756-185X.13781

[29]. Mabusela, M., Tomita, A., Paruk, S., & Paruk, F. (2022). Prevalence of depressive symptoms in patients with rheumatoid arthritis at a regional hospital in KwaZulu-Natal, South Africa. South African Journal of Psychiatry, 28. https://doi.org/10.4102/sajpsychiatry.v28i0.1702

[30]. Magalhães, N. R. de, Daleaste, V. N. F., Gomes, M. B., & Shinzato, M. M. (2023). The impact of depression and anxiety on pain reported by patients with rheumatoid arthritis undergoing treatment. Acta Scientiarum. Health Sciences, 45, e62930. https://doi.org/10.4025/actascihealthsci.v45i1.62930

[31]. Maldonado, G., Ríos, C., Paredes, C., Ferro, C., Intriago, M. J., Aguirre, C., Avila, V., & Moreno, M. (2017). Depression in rheumatoid arthritis. Revista Colombiana de Reumatología (English Edition), 24(2), 84–91. https://doi.org/10.1016/j.rcreue.2017.07.001

[32]. Malti, T., et al. (2017). Health policy: Application for nurses and other healthcare professionals. Journal of Clinical Nursing.

[33]. Matcham, F., Ali, S., Irving, K., Hotopf, M., & Chalder, T. (2016). Are depression and anxiety associated with disease activity in rheumatoid arthritis? A prospective study. BMC Musculoskeletal Disorders, 17(1), 155. https://doi.org/10.1186/s12891-016-1011-1

[34]. Matcham, F., Rayner, L., Steer, S., & Hotopf, M. (2013). The prevalence of depression in rheumatoid arthritis: A systematic review and meta-analysis. Rheumatology, 52(12), 2136–2148. https://doi.org/10.1093/rheumatology/ket169

[35]. Meade, T., Joyce, C., Perich, T., Manolios, N., Conaghan, P. G., & Katz, P. (2024). Prevalence, severity, and measures of anxiety in rheumatoid arthritis: A systematic review. Arthritis Care & Research, 76(2), 171–180. https://doi.org/10.1002/acr.25245

[36]. Moudi, S., Heidari, B., Yousefghahari, B., Gholami, R., Gholinia, H., & Babaei, M. (2023). The prevalence and correlation of depression and anxiety with disease activity in rheumatoid arthritis. Rheumatology. https://doi.org/10.5114/reum/154905

[37]. Myhydeen, Y. M. (2023). The prevalence of depression in people with rheumatoid arthritis. International Journal of Medical Science, 10(1), 25–30. https://doi.org/10.14445/23939117/IJMS-V10I1P105

[38]. Nicolau, R., Martins, A., Santos Oliveira, D., Bernardes, M., & Costa, L. (2023). AB0296 The real impact of depression and anxiety on rheumatoid arthritis patients: A cohort study. Annals of the Rheumatic Diseases, 82, 1330–1331. https://doi.org/10.1136/annrheumdis-2023-eular.2839

[39]. Pai, V., S, S., & Rawat, V. S. (2023). AB0373 Depression in rheumatoid arthritis: A cross-sectional study from a tertiary care hospital in North India. Annals of the Rheumatic Diseases, 82, 1370–1371. https://doi.org/10.1136/annrheumdis-2023-eular.6033

[40]. Panjrattan, C., Chauhan, V., Nath, S., Singh, K. R., Banyal, N., & Bajwa, M. K. (2023). Depression among rheumatoid arthritis patients and barriers to seeking professional help: An observational study. Industrial Psychiatry Journal, 32(Suppl 1), S136–S140. https://doi.org/10.4103/ipj.ipj_222_23

[41]. Pedersen, J. K., Risbo, N., Pedersen, A., Wang, L., Havregaard Sørensen, C., Andersen, K., & Ellingsen, T. (2022). OP0067 More than six-fold increased mortality risk in patients with incident rheumatoid arthritis and depression in a large cohort with 10-year follow-up. Annals of the Rheumatic Diseases, 81, 46–47. https://doi.org/10.1136/annrheumdis-2022-eular.1414

[42]. Peterson, S., Piercy, J., Blackburn, S., Sullivan, E., Karyekar, C. S., & Li, N. (2019). The multifaceted impact of anxiety and depression on patients with rheumatoid arthritis. BMC Rheumatology, 3(1), 43. https://doi.org/10.1186/s41927-019-0092-5

[43]. Pezzato, S., Bonetto, C., Caimmi, C., Tomassi, S., Montanari, I., Gnatta, M. G., Fracassi, E., Cristofalo, D., Rossini, M., Carletto, A., & Tosato, S. (2021). Depression is associated with increased disease activity and higher disability in a large Italian cohort of patients with rheumatoid arthritis. Advances in Rheumatology, 61(1), 57. https://doi.org/10.1186/s42358-021-00214-3

[44]. Pham, H. T., Vu-Thi, H., Le, C. T., Dau, Q. L., Nguyen, M. D., & Nguyen-Van, H. (2024). Characteristics of depressive disorders in patients with rheumatoid arthritis and some related factors. European Review for Medical and Pharmacological Sciences. https://doi.org/10.26355/eurrev_202401_34911

[45]. Qaiser, T., Mussadiq, S., & Iftikhar, H. (2020). The incidence of generalized anxiety disorder in patients with rheumatoid arthritis and its relationship to disease activity. Indo American Journal of Pharmaceutical Sciences. https://doi.org/10.5281/zenodo.4314147

[46]. Rabei, S., & el Sonbaty, H. (2022). Anxiety and depression regression and correlation as to rheumatoid arthritis patients' clinical and sociodemographic characteristics. Egyptian Journal of Psychiatry, 43(1), 23. https://doi.org/10.4103/ejpsy.ejpsy_10_21

[47]. Rajaei, E., Shalbaf, Z., Nazarinasab, M., & Deris Zayeri, Z. (2019). Epidemiology of depression in rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis. Jundishapur Journal of Chronic Disease Care, 8(3). https://doi.org/10.5812/jjcdc.90884

[48]. Sargın, G., Baygin, H., & Senturk, T. (2022). The anxiety and depression in rheumatoid arthritis patients treating with disease-modifying anti-rheumatic drugs during the COVID-19 pandemic. Mediterranean Journal of Rheumatology, 33(4), 430. https://doi.org/10.31138/mjr.33.4.430

[49]. Shoukry, H. S. (2021). Prevalence of depression among hospital based rheumatoid arthritis population and its associated factors. Archives of Medicine.

[50]. Sweet, N., Huang, H., & Bartels, C. M. (2025). Mind matters in rheumatoid arthritis: The rising burden of anxiety and depression. The Journal of Rheumatology, 52(3), 203–205. https://doi.org/10.3899/jrheum.2024-1273

[51]. Tokunaga, K., Oshikawa, H., Nishino, T., Matsui, T., & Tohma, S. (2023). AB0330 Evaluation of the association between mood disorders and the region of the affected joints in Japanese patients with rheumatoid arthritis: A cross-sectional study. Scientific Abstracts, 1348. https://doi.org/10.1136/annrheumdis-2023-eular.3423

[52]. Vega Sevilla, L. F., Villarreal-Alarcón, M. A., Flores-Gutierrez, D. P., De Avila Gonzalez, N., Hernandez-Galarza, I. D. J., Cardenas-de la Garza, J. A., & Galarza-Delgado, D. Á. (2023). POS0798-HPR Prevalence of risk for anxiety and depression in patients with rheumatic diseases. Annals of the Rheumatic Diseases, 82, 692–693. https://doi.org/10.1136/annrheumdis-2023-eular.2788

[53]. Vestergaard, S. B., Esbensen, B. A., Klausen, J. M., Glintborg, B., Lau, L., Yilmaz Jantzen, C., Aadahl, M., Fevejle Cromhout, P., & de Thurah, A. (2024). Prevalence of anxiety and depression and the association with self-management behaviour in >12,000 patients with inflammatory rheumatic disease: A cross-sectional nationwide study. RMD Open, 10(1), e003412. https://doi.org/10.1136/rmdopen-2023-003412

[54]. World Health Organization. (2023). Rheumatoid arthritis. https://www.who.int/news-room/fact-sheets/detail/Rheumatoid-arthritis